Edition:
United Kingdom

Mirati Therapeutics Inc (MRTX.OQ)

MRTX.OQ on NASDAQ Stock Exchange Capital Market

17.80USD
15 Dec 2017
Change (% chg)

$0.50 (+2.89%)
Prev Close
$17.30
Open
$17.30
Day's High
$18.45
Day's Low
$17.20
Volume
1,117,867
Avg. Vol
187,809
52-wk High
$19.10
52-wk Low
$2.70

Select another date:

Mon, Nov 13 2017

BRIEF-Mirati announces advancement of opportunities with inhibitor programs

* Mirati Therapeutics announces advancement of first-in-class opportunities with sitravatinib and kras inhibitor programs

BRIEF-Mirati Therapeutics reports Q3 loss per share of $0.65

* Mirati Therapeutics reports third quarter 2017 financial results

BRIEF-Mirati Therapeutics' says drug included in Stand Up To Cancer's clinical trial initiative for NSCLC patients

* Mirati Therapeutics' mocetinostat included in stand up to cancer's cutting-edge clinical trial initiative for NSCLC patients Source text for Eikon: Further company coverage:

BRIEF-Mirati Therapeutics presents positive data from on-going clinical trials of sitravatinib

* Mirati Therapeutics Inc presents positive preliminary data from on-going clinical trials of sitravatinib in non-small cell lung cancer

BRIEF-Mirati Therapeutics reports Q2 loss per share $0.74

* Mirati Therapeutics reports second quarter 2017 financial results

Select another date: